Compare PRU & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRU | BDX |
|---|---|---|
| Founded | 1875 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.4B | 43.0B |
| IPO Year | 2001 | 1998 |
| Metric | PRU | BDX |
|---|---|---|
| Price | $119.76 | $179.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $103.71 | ★ $186.00 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.81% | 2.89% |
| EPS Growth | ★ 33.20 | N/A |
| EPS | ★ 4.48 | 1.59 |
| Revenue | ★ $60,774,000,000.00 | $21,840,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.06 | $3.02 |
| P/E Ratio | ★ $27.24 | $116.19 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $91.89 | $140.11 |
| 52 Week High | $127.72 | $213.08 |
| Indicator | PRU | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 48.57 |
| Support Level | $117.63 | $141.69 |
| Resistance Level | $126.21 | $187.35 |
| Average True Range (ATR) | 2.36 | 3.88 |
| MACD | -0.29 | -1.76 |
| Stochastic Oscillator | 36.88 | 13.15 |
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2025 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 39% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 11% of its 2025 adjusted earnings. PGIM had around $1.47 trillion in assets under management at the end of fourth-quarter 2025.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.